Premature placental senescence in early-onset preeclampsia: syncytiotrophoblast SASP and the maternal syndrome
Frontiers in Public Health · 14.07.2026 · 14
DOI: 10.3389/fpubh.2026.1863387 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Public Health, online erschienen am 14.07.2026. Verfasst von Meifang Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Ch…. Hauptthemen laut MEDLINE: Pre-Eclampsia, Trophoblasts, Placenta, Senescence-Associated Secretory Phenotype. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Early-onset preeclampsia (EOPE) remains a leading cause of maternal and perinatal morbidity worldwide. This review synthesizes evidence that premature placental senescence, centered on syncytiotrophoblast stress and the senescence-associated secretory phenotype (SASP), provides a mechanistic framework connecting placental injury to the maternal syndrome. In EOPE, defective spiral artery remodeling (45) and repeated ischemia–reperfusion can promote oxidative damage, persistent DNA-damage responses, impaired autophagy, and durable cell-cycle arrest in trophoblast lineages. Convergent data show elevated senescence markers (p16INK4a, p21, SA- β -galactosidase, γ -H2AX), transcriptomic signatures consistent with placental SASP programs, and senescent syncytiotrophoblast secretion—PAI-1 (~4-fold) and activin A (~2-fold). The SASP can transform the placenta into a source of cytokines, antiangiogenic factors, cell-free nucleic acids, and extracellular vesicles that may bias the maternal circulation toward endothelial dysfunction. We propose a stage-based model of EOPE progression and discuss differences from late-onset disease. Senescence-linked circulating signals may support multimarker risk stratification and liquid-biopsy strategies. We emphasize that human causal evidence remains associative and the senescence model is best regarded as a testable framework complementing established immune, complement, and angiogenic models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
- Zhejiang Provincial Clinical Research Center for Reproductive Health and Disease, Hangzhou, China.
- Dalian Medical University, Dalian, China.
Zitieren
APA
Zhou, M., Zhang, S., & Hong, S. (2026). Premature placental senescence in early-onset preeclampsia: syncytiotrophoblast SASP and the maternal syndrome. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1863387
Vancouver
Zhou M, Zhang S, Hong S. Premature placental senescence in early-onset preeclampsia: syncytiotrophoblast SASP and the maternal syndrome. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1863387
BibTeX
@article{Zhou2026,
author = {Zhou, Meifang and Zhang, Shuni and Hong, Shihao},
title = {Premature placental senescence in early-onset preeclampsia: syncytiotrophoblast SASP and the maternal syndrome},
journal = {Frontiers in Public Health},
year = {2026},
volume = {14},
doi = {10.3389/fpubh.2026.1863387}
}
EUVIMED